Asahi Kasei Corporate Venture Capital

Glycomine, Inc. is a biotech company focused on developing nanomedicines for rare genetic disorders, particularly those related to protein and lipid glycosylation, which can severely impact patients' health. Established in 2014 and located in San Carlos, California, Glycomine aims to address the significant unmet medical need for effective treatments in the realm of rare diseases, where approximately 95% lack any FDA-approved therapies. The company specializes in creating replacement therapies that utilize a combination of substrates, enzymes, and proteins, delivered through bio-nano materials that target specific cells within clinically relevant organs. By innovating in this area, Glycomine seeks to provide new therapeutic options for patients suffering from disorders of metabolism and protein misfolding.

Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

Koya Medical, Inc., founded in 2018 and based in Oakland, California, specializes in developing innovative therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. The company focuses on creating wearable technology that delivers active compression therapy, which is designed to enhance movement and mobility for patients. Koya Medical's approach offers a personalized alternative to traditional compression methods, utilizing a sensor-based closed-loop system to provide tailored compression patterns. This technology addresses the needs of patients suffering from conditions such as lymphedema, chronic edema, and chronic venous insufficiency, thereby improving their quality of care and overall treatment outcomes.

Rege Nephro Co., Ltd., established in 2019 and based in Kyoto, Japan, is a biotech company focused on the research, development, production, and marketing of therapeutics for renal diseases. The company leverages induced pluripotent stem cell (iPSC) technology, sourced from the Center for iPS Cell Research and Application at Kyoto University, to create innovative treatments for kidney, liver, and pancreas conditions. Rege Nephro develops drugs that utilize core seeds technology, which includes pluripotent stem cells capable of producing erythropoietin (EPO) and specific nephron progenitor cell markers. This approach aims to minimize the reliance on dialysis among patients with renal failure by offering effective therapeutic alternatives. Additionally, the company produces kidney organoids designed for nephrotoxicity screening, facilitating drug discovery in applied research.

Aerobiotix is a privately held company focused on developing and manufacturing proprietary environmental management devices. Its products are designed for use in institutional healthcare, home health, and commercial settings. The company provides a range of innovative technologies that effectively eliminate airborne viruses, bacteria, and spores, thereby enhancing indoor air quality and optimizing the overall environment.

Hazel Technologies, Inc. is a biotechnology company focused on reducing waste in the agricultural supply chain through innovative packaging solutions. Founded in 2015 and headquartered in Chicago, Illinois, with an additional location in Salinas, California, the company designs packaging inserts, known as sachets, that are placed in produce boxes at harvest. These sachets slow down the aging process of fruits and vegetables by controlling the storage atmosphere and inhibiting ethylene, which helps to extend shelf life and prevent spoilage. Hazel Technologies also offers horticultural consulting services to growers and shippers, working to improve the efficiency of the fresh produce supply chain. Their product development is supported by the United States Department of Agriculture, with performance validated by third-party research institutions. By providing effective shelf-life extension technologies and services, Hazel Technologies aims to combat global food waste and enhance profitability for its customers.

Firework provides video commerce solutions designed for websites, applications, and retail environments. The company operates a storytelling platform that facilitates live streaming videos directly on websites. This platform includes features such as in-video shopping, lead generation, and live-streaming events. Additionally, it allows brands to import and edit videos, enhancing their ability to engage and convert visitors on their websites. Through these offerings, Firework aims to enrich the online shopping experience and drive customer interaction.

Shenzhen Dami He Xiaomi Cultural Broadcast Co., Ltd., known as Dami & Xiaomi, operates an online platform dedicated to supporting children with autism spectrum disorders. Established in 2014 and based in Shenzhen, China, the company offers a range of integrated services including rehabilitation, educational support, parent training, online courses, and science information. Dami & Xiaomi aims to address the needs of children with developmental disorders, focusing on effective strategies to help them manage autism and promote healthy growth. Through its comprehensive platform, it provides essential resources to empower parents and caregivers in their efforts to support their children's development.

Hazel Technologies, Inc. is a biotechnology company focused on reducing waste in the agricultural supply chain through innovative packaging solutions. Founded in 2015 and headquartered in Chicago, Illinois, with an additional location in Salinas, California, the company designs packaging inserts, known as sachets, that are placed in produce boxes at harvest. These sachets slow down the aging process of fruits and vegetables by controlling the storage atmosphere and inhibiting ethylene, which helps to extend shelf life and prevent spoilage. Hazel Technologies also offers horticultural consulting services to growers and shippers, working to improve the efficiency of the fresh produce supply chain. Their product development is supported by the United States Department of Agriculture, with performance validated by third-party research institutions. By providing effective shelf-life extension technologies and services, Hazel Technologies aims to combat global food waste and enhance profitability for its customers.

Feldan Therapeutics is a biopharmaceutical company focused on developing innovative treatments using its proprietary peptide-based technology platform, known as the Feldan Shuttle. This platform facilitates fast and safe intracellular delivery, allowing access to cellular components that are typically unreachable by conventional drugs. By leveraging the unique characteristics of the Feldan Shuttle, the company aims to create a new generation of therapeutic applications, as evidenced by its ongoing pipeline of clinical programs. Feldan Therapeutics is committed to advancing the field of intracellular therapeutics to improve patient outcomes.